Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO)

International Journal of Radiation Oncology, Biology, Physics
Rémi DendaleLaurence Desjardins

Abstract

This study reports the results of proton beam radiotherapy based on a retrospective series of patients treated for uveal melanoma at the Orsay Center. Between September 1991 and September 2001, 1,406 patients with uveal melanoma were treated by proton beam radiotherapy. A total dose of 60 cobalt Gray equivalent (CGE) was delivered in 4 fractions on 4 days. Survival rates were determined using Kaplan-Meier estimates. Prognostic factors were determined by multivariate analysis using the Cox model. The median follow-up was 73 months (range, 24-142 months). The 5-year overall survival and metastasis-free survival rates were 79% and 80.6%, respectively. The 5-year local control rate was 96%. The 5-year enucleation for complications rate was 7.7%. Independent prognostic factors for overall survival were age (p < 0.0001), gender (p < 0.0003), tumor site (p < 0.0001), tumor thickness (p = 0.02), tumor diameter (p < 0.0001), and retinal area receiving at least 30 CGE (p = 0.003). Independent prognostic factors for metastasis-free survival were age (p = 0.0042), retinal detachment (p = 0.01), tumor site (p < 0.0001), tumor volume (p < 0.0001), local recurrence (p < 0.0001), and retinal area receiving at least 30 CGE (p = 0.002). Independ...Continue Reading

References

May 1, 1977·American Journal of Ophthalmology·E S GragoudasI J Constable
Nov 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M BentzenJ Meder
Mar 1, 1986·Archives of Ophthalmology·A F Brovkina, G D Zarubei
Nov 1, 1966·The British Journal of Ophthalmology·H B Stallard
Mar 1, 1966·The British Journal of Ophthalmology·H B Stallard
May 1, 1983·Medical Physics·M Goitein, T Miller
Jun 1, 1980·Ophthalmology·D H CharA Schwartz
May 4, 1996·Lancet·G PrescherR Becher
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·A CourdiP Chauvel
Mar 22, 2000·International Journal of Radiation Oncology, Biology, Physics·J BourhisF Eschwege
Mar 10, 2001·International Journal of Radiation Oncology, Biology, Physics·M FussJ D Slater
Oct 24, 2001·The British Journal of Ophthalmology·L LumbrosoB Asselain
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Y BelkacémiJ M Warnet
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Helen AthanassiouUNKNOWN Oncology Hellenic Group
Jul 2, 2003·American Journal of Ophthalmology·Devron H CharTheodore L Phillips
Aug 2, 2003·Stereotactic and Functional Neurosurgery·Georges NoëlJean-Jacques Mazeron
Sep 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Dosia AntonadouMaria Synodinou

❮ Previous
Next ❯

Citations

Feb 26, 2009·Australasian Physical & Engineering Sciences in Medicine·S J DowdellA B Rosenfeld
Sep 8, 2010·Radiological Physics and Technology·Kenneth SutherlandToshiki Tajima
Nov 24, 2012·Eye·C StannardK Lecuona
Nov 28, 2012·Nature Reviews. Clinical Oncology·Juliette ThariatJean-Pierre Gérard
Aug 13, 2009·The Cancer Journal·Daniela Schulz-Ertner
Aug 13, 2009·The Cancer Journal·Thomas E Merchant
May 7, 2013·The British Journal of Ophthalmology·Melinda Y Chang, Tara A McCannel
Oct 23, 2012·Radiation Oncology·Robert L FooteRobert B Diasio
Nov 4, 2011·Medical Physics·G AngellierJ Herault
Oct 31, 2013·The British Journal of Ophthalmology·Nathalie CassouxJérôme Couturier
Mar 24, 2011·The British Journal of Radiology·A D JensenJ Debus
Apr 17, 2009·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Geertruida E BekkeringJos Kleijnen
Feb 20, 2014·American Journal of Ophthalmology·Aline I RiechardtAntonia M Joussen
Jul 28, 2013·International Journal of Radiation Oncology, Biology, Physics·Kavita K MishraDevron H Char
Feb 27, 2016·Clinical Oncology : a Journal of the Royal College of Radiologists·V Verma, M P Mehta
Nov 3, 2012·Hematology/oncology Clinics of North America·Yoshihiro Yonekawa, Ivana K Kim
Aug 21, 2012·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·D AzriaF Mornex
Sep 29, 2011·International Journal of Radiation Oncology, Biology, Physics·Roman DunavoelgyiRichard Poetter
Jun 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Christoph A AmstutzJens H Kowal
Nov 26, 2010·International Journal of Radiation Oncology, Biology, Physics·Atsushi MizotaYoshiya Furusawa
Apr 30, 2010·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A Bouyon-MonteauP Bey
May 18, 2010·International Journal of Radiation Oncology, Biology, Physics·Laura MarucciJohn E Munzenrider
Mar 20, 2009·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·P SevretJ-L Habrand
Jun 12, 2008·Seminars in Oncology·Joseph K Salama, Everett E Vokes
May 16, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mark LodgeTom Jefferson
Sep 10, 2008·Acta Ophthalmologica·Raffaele ParrozzaniEdoardo Midena
Oct 19, 2016·Acta Ophthalmologica·Stéphanie LemaîtreNathalie Cassoux
Aug 1, 2015·The British Journal of Ophthalmology·Gregor D WillerdingNikolaos E Bechrakis
Apr 17, 2016·International Journal of Radiation Oncology, Biology, Physics·Jan HrbacekDamien C Weber
Apr 17, 2016·International Journal of Radiation Oncology, Biology, Physics·William F HartsellMark Pankuch
Apr 17, 2016·International Journal of Radiation Oncology, Biology, Physics·Juliette ThariatJean-Pierre Caujolle
Aug 21, 2014·The British Journal of Ophthalmology·Lazaros KonstantinidisBertil Damato
Jan 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Eric TranTom Pickles
Nov 16, 2010·International Journal of Radiation Oncology, Biology, Physics·Valentin CalugaruFrédérique Mégnin-Chanet
Jun 29, 2011·International Journal of Radiation Oncology, Biology, Physics·Rolina Al-WassiaGeorge Shenouda
Nov 28, 2012·International Journal of Radiation Oncology, Biology, Physics·Jean-Pierre CaujolleJean Michel Hannoun-Levi
Aug 26, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Karin MullerGré P M Luyten
Mar 13, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Aaron M AllenAndre A Konski
Sep 21, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Roman DunavoelgyiKarin Dieckmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Bertil DamatoR Douglas Errington
International Journal of Radiation Oncology, Biology, Physics
Emmanuel EggerG Goitein
International Journal of Radiation Oncology, Biology, Physics
Jean-Pierre CaujolleP Gastaud
International Journal of Radiation Oncology, Biology, Physics
A CourdiP Chauvel
© 2022 Meta ULC. All rights reserved